Vectorite Biomedical Inc. (TPEX:4170)
Taiwan · Delayed Price · Currency is TWD 13.15
0.00 (0.00%)
Mar 25, 2026, 9:33 AM CST
Vectorite Biomedical Market Cap
Vectorite Biomedical has a market cap or net worth of 575.59 million as of March 24, 2026. Its market cap has decreased by -6.74% in one year.
Market Cap
575.59M
Enterprise Value
399.74M
Revenue
67.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.15
Market Cap Chart
Since April 15, 2013, Vectorite Biomedical's market cap has increased from 393.23M to 575.59M, an increase of 46.37%. That is a compound annual growth rate of 2.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 575.59M | -6.07% |
| Dec 31, 2025 | 612.80M | -3.45% |
| Dec 31, 2024 | 634.68M | -32.08% |
| Dec 29, 2023 | 934.52M | 49.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeneReach Biotechnology | 1.09B |
| Level Biotechnology | 1.08B |
| Holy Stone Healthcare | 1.03B |
| TCI GENE | 965.74M |
| Taiwan Advance Bio-Pharmaceutical | 936.00M |
| NatureWise Biotech & Medicals | 916.55M |
| Neith | 899.73M |
| Eusol Biotech | 842.55M |